<table border="single" id="id_53939cd2-7140-4872-b48d-5f26e5e858c8" width="443.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_b652db7b-16a7-4eb7-85e1-d2b50484c5f1">Mean Changes from Baseline in Glycemic Parameters and Weight in a 24-Week PRANDIN/Rosiglitazone Combination Study<footnote id="id-777a8991-7ceb-434b-b9e3-47accf3876bd">based on intent-to-treat analysis</footnote>
</caption>
<col width="26.9%"></col>
<col width="22.1%"></col>
<col width="25.5%"></col>
<col width="25.5%"></col>
<tbody>
<tr id="id_954581e4-ab51-4ced-bf49-e87d814ae987">
<td align="left" stylecode="Botrule Toprule Rrule" valign="top"></td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">PRANDIN</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Combination</content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<content stylecode="bold">Rosiglitazone</content>
</td>
</tr>
<tr id="id_1f31394c-6b17-4d43-8997-437afe962c01">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">N</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">63</td>
<td align="center" stylecode="Botrule Rrule" valign="top">127</td>
<td align="center" stylecode="Botrule" valign="top">62</td>
</tr>
<tr id="id_90c5ea6c-b61b-430f-89d6-dbd71cb892bf">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">HbA<sub>1c</sub> (%)</content>
</td>
<td align="center" colspan="3" stylecode="Botrule" valign="top"></td>
</tr>
<tr id="id_e9c3e6b6-8b9d-4d30-b78d-0abebf54badb">
<td align="left" stylecode="Botrule Rrule" valign="top"> Baseline</td>
<td align="center" stylecode="Botrule Rrule" valign="top">9.3</td>
<td align="center" stylecode="Botrule Rrule" valign="top">9.1</td>
<td align="center" stylecode="Botrule" valign="top">9.0</td>
</tr>
<tr id="id_a71dcbc5-311c-4155-bc84-dc5ccaa2b95c">
<td align="left" stylecode="Botrule Rrule" valign="top"> Change by 24 weeks</td>
<td align="center" stylecode="Botrule Rrule" valign="top">-0.17</td>
<td align="center" stylecode="Botrule Rrule" valign="top">-1.43 <footnote id="id-f5f6d4a4-df6b-416b-a34e-522755b669f9">p-value â‰¤ 0.001 for comparison to either monotherapy</footnote>
</td>
<td align="center" stylecode="Botrule" valign="top">-0.56</td>
</tr>
<tr id="id_6c00d245-4fb1-4e83-ad76-218b88a8664e">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">FPG (mg/dL)</content>
</td>
<td align="center" colspan="3" stylecode="Botrule" valign="top"></td>
</tr>
<tr id="id_505d202f-7818-4530-b66c-5535e46f550c">
<td align="left" stylecode="Botrule Rrule" valign="top"> Baseline</td>
<td align="center" stylecode="Botrule Rrule" valign="top">269</td>
<td align="center" stylecode="Botrule Rrule" valign="top">257</td>
<td align="center" stylecode="Botrule" valign="top">252</td>
</tr>
<tr id="id_99d4e2ba-e13d-4439-901c-862f9c7c2ce0">
<td align="left" stylecode="Botrule Rrule" valign="top"> Change by 24 weeks</td>
<td align="center" stylecode="Botrule Rrule" valign="top">-54</td>
<td align="center" stylecode="Botrule Rrule" valign="top">-94 <footnoteref idref="id-f5f6d4a4-df6b-416b-a34e-522755b669f9"></footnoteref>
</td>
<td align="center" stylecode="Botrule" valign="top">-67</td>
</tr>
<tr id="id_7190ee7f-7afb-4f25-b2bb-753f9e592544">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Change in Weight (kg)</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">+1.3</td>
<td align="center" stylecode="Botrule Rrule" valign="top">+4.5 <footnote id="id-7923d8b6-4729-4147-80ea-a5bd455a7d6c">p-value &lt; 0.001 for comparison to PRANDIN</footnote>
</td>
<td align="center" stylecode="Botrule" valign="top">+3.3</td>
</tr>
<tr id="id_a5810041-0c42-4a5e-9f99-c0f95d5d8c74">
<td align="left" colspan="4" stylecode="Lrule Botrule" valign="top">
<paragraph>Final median doses: rosiglitazone - 4 mg/day for combination and 8 mg/day for monotherapy; PRANDIN - 6 mg/day for combination and 12 mg/day for monotherapy </paragraph>
</td>
</tr>
</tbody>
</table>